Characteristics | N (%)a |
---|---|
Age (mean [range]) (years) | 60.7 [26–85] |
Male | 46 (78.0) |
MRSAB | 36 (61.0%) |
Length of total hospital stay (median [IQR]) (d) | 27.0 [17.0–46.0] |
Duration of bacteremia (median [IQR]) (d) | 2.0 [1.0–4.0] |
Onset of infection | |
 Community-associated | 11 (18.6) |
 Community-onset, healthcare-associated | 22 (37.3) |
 Hospital-onset | 26 (44.1) |
In ICU at first positive blood culture | 5 (8.5) |
CCWI score (median [IQR]) | 5.0 [2.0–7.0] |
Pitt bacteremia score (median [IQR]) | 1.0 [0.0–3.0] |
SOFA score (median [IQR]) | 4.0 [1.0–8.0] |
Severity | |
 Non-sepsis | 9 (15.3) |
 Sepsis | 35 (59.3) |
 Severe sepsis | 8 (13.6) |
 Septic shock | 7 (11.9) |
Primary site of infection | |
 Central venous catheter | 15 (25.4) |
 Bone and joint | 14 (23.7) |
 Skin and soft tissue | 7 (11.9) |
 Lower respiratory tract | 6 (10.2) |
 Cardiovascular siteb | 9 (15.3) |
 Unknown | 6 (10.2) |
 Othersc | 2 (3.4) |
Treatment | |
 Appropriate empirical | 40 (67.8) |
 Appropriate definitived | 59 (100) |
Time until appropriate antibiotic (mean ± SD) (h) | 30.5 ± 26.3 |
SAB-related 30-day mortality | 10 (16.9) |
Persistent SAB | 14 (23.7%) |
Metastatic SAB | 6 (10.2) |